IP Library › Granted Patent US 12,503,488
Granted Patent B2
US 12,503,488 · App. 17/796,720 · Granted Dec 23, 2025

Reuse of intein-bound resins for protein purification

Inventors: Oliver Rammo (Darmstadt, DE); Romas Skudas (Darmstadt, DE)
Assignee: Merck Patent GmbH
C07K1/22B01J49/00C07K2319/92
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,503,488
App. No.
17/796,720
Granted
Dec 23, 2025
Kind
B2
Abstract

The present disclosure relates to methods of protein purification by attaching an intein-C fragment to a target protein, passing a sample containing the intein-C tagged protein over a chromatographic resin carrying an intein-N fragment so as to create an intein-N intein-C complex, releasing the target protein from the intein-C fragment, and regenerating the column under conditions that disrupt the intein-N intein-C complex while preserving column functionality for multiple reuses.

Claims (29)

1 . A method for purifying a target molecule in a sample, the method comprising the steps of

(a) providing a sample containing a fusion protein comprising an intein-C polypeptide joined to a target molecule by a peptide bond (intein-C tagged target molecule);

(b) contacting the sample with a chromatography resin comprising a covalently-linked N-terminal intein polypeptide, under conditions in which the intein-C polypeptide in the fusion protein binds to the intein-N polypeptide in the resin to form an intein complex;

(c) optionally washing the resin containing the intein complex to remove unbound contaminants;

(d) exposing the intein complex to conditions sufficient to release the target molecule from the intein-C polypeptide;

(e) regenerating the chromatographic resin by contacting the resin with a composition having a pH in aqueous solution of about 1 to about 4;

so as to disrupt the intein-N intein-C complex and release the intein-C polypeptide from the chromatography resin; and

(f) optionally, performing at least one additional purification cycles by repeating steps (a) to (e) at least once,

wherein the regenerated chromatography resin obtained from step (e) or optional step (f) retains at least about 60%, preferably at least about 70% and more preferably at least about 80% of its C-terminal intein binding capacity after each purification cycle.

2 . The method according to claim 1 , wherein in step (e) the aqueous solution has a pH of about 1 to about 2.

3 . The method according to claim 1 , wherein step (e) further comprises regenerating the chromatographic resin by contacting the resin with at least one detergent.

4 . The method according to claim 1 , wherein step (e) further comprises regenerating the chromatographic resin by contacting the resin with a composition comprising at least one kosmotropic agent.

5 . The method according to claim 1 , wherein step (e) further comprises regenerating the chromatographic resin by contacting the resin with a composition comprising at least one chaotropic agent.

6 . The method according claim 1 , further comprising the step of performing at least one purification cycle wherein the resin is contacted with a basic composition having a pH in aqueous solution of about 9 or higher.

7 . The method according to claim 1 , wherein the intein-C tagged target molecule is prepared by attaching an intein-C polypeptide to a target molecule to obtain a fusion protein, and expressing the fusion protein in an expression system.

8 . The method according to claim 1 , wherein step (b) comprises contacting the chromatography resin with a cell culture supernatant comprising the intein-C tagged target molecule; or wherein step (b) comprises loading the intein-C tagged target molecule in a saline buffer having a pH of about 8 to about 10.

9 . The method according to claim 1 , wherein step (c) is performed, and comprises washing the chromatography resin with a washing buffer prior to releasing the target molecule from the intein-C polypeptide.

10 . The method according to claim 1 , wherein step (d) comprises contacting the resin with a cleavage buffer having a pH of about 6 to about 8, so as to release the target molecule from the intein-C polypeptide.

11 . The method according to claim 1 , wherein the composition having a pH in aqueous solution of about 1 to about 4 comprises an acidic buffer comprising an acid selected from the group consisting of phosphoric acid, glycine, hydrochloric acid, hydrobromic acid, citric acid, acetic acid, formic acid, lactic acid, carbonic acid, succinic acid, nitric acid, malic acid, oxalic acid, salicylic acid, formic acid, and any combinations thereof.

12 . The method according to claim 3 ,

wherein the detergent is selected from the group consisting of anionic detergents, cationic detergents, non-ionic detergents and zwitter ionic detergents.

13 . The method according to claim 1 , further comprising the step of isolating the target molecule obtained from step (d).

14 . The method according to claim 1 , wherein the chromatography resin is polymer based or includes a polymer.

15 . The method of claim 14 , wherein the chromatography resin is formulated on a solid support, wherein the solid support is a bead or a membrane.

16 . The method according to claim 1 , wherein the target molecule is a protein.

17 . The method according to claim 1 , wherein the intein-N polypeptide is attached to the chromatography resin through a functional group selected from the group consisting of hydroxyl, thiol, epoxide, amino, carbonyl epoxide and carboxylic acid.

18 . The method according to claim 12 , wherein the detergent is selected from polysorbates, polyethylene glycols, glycosides, poloxamers, 3-[(3-Cholamidopropyl)dimethylammonio]-1-propanesulfonate, 3-[(3-Cholamidopropyl)dimethylammonio]-2-hydroxy-1-propanesulfonate, alkylbenzenesulfonates, quaternary ammonium salts, and bile acids.

19 . The method according to claim 4 , wherein the kosmotropic agent is an ionic kosmotropic agent or a nonionic kosmotropic agent selected from the group consisting of carbohydrates, amino acids and alcohols.

20 . The method according to claim 5 , wherein the chaotropic agent is selected from the group consisting of guanidinium chloride, arginine, n-butanol, ethanol, lithium perchlorate, lithium acetate, magnesium chloride, phenol, 2-propanol, sodium dodecyl sulfate, thiourea, urea, and any combination thereof.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 1, 2022
From: RAMMO, OLIVER; SKUDAS, ROMAS
To: MERCK KGAA
Reel/Frame 060683/0618 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 1, 2022
From: MERCK KGAA
To: MERCK LIFE SCIENCE GERMANY GMBH
Reel/Frame 060683/0665 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 1, 2022
From: MERCK LIFE SCIENCE GERMANY GMBH
To: MERCK PATENT GMBH
Reel/Frame 060683/0715 →
Priority Claims (1)
EP 20165535 · Mar 25, 2020 · regional
Continuity (1)
Related Publication 20230064395A1 · Mar 2, 2023
References Cited (21)
US 9149738B2 · Skudas · 2015 [cited by third party]
US 10087213B2 · Chen · 2018 [cited by third party]
US 11124539B2 · Ohman · 2021 [cited by third party]
US 11326154B2 · Zillmann · 2022 [cited by third party]
US 20150353597A1 · Chen et al. · 2015 [cited by applicant]
US 20240132538A1 · Sevinsky · 2024 [cited by examiner]
CN 101884910A · 2010 [cited by third party]
WO 2014110393A1 · 2014 [cited by applicant]
International Search Report dated Jun. 23, 2021 issued in corresponding PCT/EP2021/057399 application (3 pages). [cited by applicant]
H.M. Beyer et al., “The Crystal Structure of the Naturally Split GP41-1 Intein Guides The Engineering of Orthogonal Split Inteins From Cis-Splicing Inteins”, The FEBS Journal, vol. 287 (2020) pp. 1886-1898. [cited by applicant]
D. Guan et al., “Split Intein Mediated Ultra-Rapid Purification of Tagless Protein (SIRP)”, Biotechnology and Bioengineering, vol. 110, No. 9 (Sep. 2013) pp. 2471-2481. [cited by applicant]
Search Report in corresponding EP appln. 21 713 035.0 dated Oct. 6, 2023 (pp. 1-5). [cited by applicant]
Meredith a Cooper: “Creating an Efficient Biopharmaceutical Factory: Protein Expression and Purification Using a Self-Cleaving Split Intein”, Pho Thesis, Ohio State University, US, Jan. 1, 2018 (Jan. 1, 2018), pp. 1-175… [cited by applicant]
Miquel Vila-Perella et al: 58 page Supplementary information to “Streamlined Expressed Protein Ligation Using Split inteins”, Journal of the American Chemical Society, vol. 135, No. 1, Jan. 9, 2013 (Jan. 9, 2013), pp. 2… [cited by applicant]
Vila-Perella Miquel et al: “Streamlined Expressed Protein Ligation Using Split Inteins”, Journal of the American Chemical Society, vol. 135, No. 1, Jan. 9, 2013 (Jan. 9, 2013), pp. 286-292, XP093086592, ISSN: 0002-7863,… [cited by applicant]
Frieden Carl, Protein-protein interaction and enzymatic activity, Annual Review of Biochemistry, Jul. 1971, vol. 40, pp. 653-696. ISSN: 0066-4154, DOI:10.1146/annurev.bi.40.070171.003253. Number of pages submitted: 46 S… [cited by third party]
Chen Lixin, Pradhan S., Evans T.C. Jr. Herbicide resistance from a divided EPSPS protein: the split Synechocystis DnaE intein as an in vivo affinity domain, Gene; vol. 263 issues 1-2, Jan. 24, 2001, pp. 39-48. ISSN 0378… [cited by third party]
Lu Wei, Sun Z., Tang Y., Chen J., Tang F., Zhang J., Liu J.N., Split intein facilitated tag affinity purification for recombinant proteins with controllable tag removal by inducible auto-cleavage, Journal of Chromatogra… [cited by third party]
Tzu-Chiang Han, Control of Intein-Mediated Self-Cleaving Tag for Recombinant Protein Purification, Dissertation, 2016, pp. 1-179. (Online access http://rave.ohiolink.edu/etdc/view?acc_num=osu1453206997) Deposited at Ohi… [cited by third party]
Merideth Ann Cooper, Creating an Efficient Biopharmaceutical Factory: Protein Expression and Purification Using a Self-Cleaving Split Intein, (Doctoral Dissertation), Deposited at Ohio State University: May 7, 2018 (pub… [cited by third party]
Grönberg, Anna; Hjorth, R.A.; Cleaning-in-Place and Sanitization (Chapter33); Biopharmaceutical Processing Development, Design, and Implementation of Manufacturing Processes; 1st Edition; Jagschies, G., Lindskog, E., La… [cited by third party]